Isabel Garcia Fructuoso
@IsabelGarciaFr6
Followers
297
Following
964
Media
5
Statuses
330
Medical Oncologist, PhD student. Translational Genomics and Targeted Therapeutics in Solid Tumors Lab - IDIBAPS. Breast Cancer Unit - Hospital Clinic Barcelona.
Vilanova i la Geltrú, Spain
Joined October 2020
RT @_SOLTI: We never forget a poll. Not at all 😉 After the gala and the office opening… we’re back with this week’s POLL OF THE WEEK result….
0
1
0
RT @_SOLTI: We’re kicking off the final POLL OF THE WEEK series featuring Dr. @IsabelGarciaFr6 before the summer break! ☀️. ❓In a patient w….
0
1
0
RT @_SOLTI: 📊In this week's POLL OF THE WEEK with Dr. @IsabelGarciaFr6 we are sharing a clinical case: . 👩Patient with HER2+ breast cancer….
0
1
0
RT @_SOLTI: In the last week's POLL OF THE WEEK we asked about SERENA-6 plenary presentation at #ASCO25📊. Dr. @IsabelGarciaFr6 shares her c….
0
2
0
RT @_SOLTI: Start the post-congress week with a new POLL OF THE WEEK featuring @IsabelGarciaFr6!. After the SERENA-6 plenary presentation a….
0
1
0
RT @LoiSher: 👏👏amazing 40m med PFS with TDXD+P v 20m THP. If 2L TDXD (DB03) is 28m PFS v 6m TDM1, does the maths favour 1L THP➡️2L TDXD? +….
0
2
0
Very curious to see what everyone thinks while we wait for the ASCENT-04 data coming in the next few days….What would be your preferred first-line treatment in this setting?. 👇👇👇👇👇🗳️🗳️🗳️.
There is NO STOP on our POLL OF THE WEEK! Next one!. In a newly diagnosed case of metastatic triple-negative #breastcancer with a known germline BRCA pathogenic variant and PDL1 positive, what would be your preferred first-line treatment?. Dr. @IsabelGarciaFr6 will comment the.
0
0
3
RT @OncobitesTv: 📊 ¿Pertuzumab adyuvante para todos los HER2+?.En #ESMOBREAST25, la Dra. @IsabelGarciaFr6 revisa los datos a +11 años del e….
0
1
0
RT @_SOLTI: So. How do you feel after ESMOBreast? Are you ready to answser the next POLL OF THE WEEK WITH Dr. @IsabelGarciaFr6? 👇. In an….
0
1
0
RT @_SOLTI: So. What about DESTINY-Breast09? Did you answer this last week's poll?. If you didn't, watch Dr. @IsabelGarciaFr6 discuss the….
0
1
0
RT @elia_segui: Loved the discussion led by @DavidCescon at #ESMOBreast2025! Fully agree that for patients with access to T-DXd in 2L, cape….
0
12
0
RT @JAMouabbi: Update from the #EMBER3 trial based on subgroup analysis.👀 at the curve in patients with co-mutated #ESR1 and #PIK3CA. @myES….
0
17
0
RT @ElisaAgostinett: At #ESMOBreast25 @fedrophd presents predictive factors of fertility in the POSITIVE trial 🤰🏼👶🏻. Lower age and no prior….
0
9
0
RT @OncobitesTv: 🎥 HOY ha empezado #ESMOBreast25 | Cobertura diaria con #OncoBites. 👩⚕️ Desde hoy, tres referentes en cáncer de mama te tr….
0
1
0
RT @aftimosp: At the proffered papers session 1, @CristinaSaura3 presents subgroup analyses from the EMBER-3: . ✅ Imlunestrant + Abemacicli….
0
26
0
RT @_SOLTI: And we are ready for the next #PollOfTheWeek!📊. Considering the positive preliminary results from the DESTINY-Breast09 trial, w….
0
1
0
RT @_SOLTI: YES! @IsabelGarciaFr6 is now fully engaged with our POLL OF THE WEEK. Did you vote on our last poll? It was quite a controversi….
0
4
0
Muy feliz de haber recogido este premio en nombre de @OlgaMartnezSez1 de esas mujeres que hacen que parezca fácil ser mujer en el mundo de la ciencia. Le debo muchas enseñanzas. Gracias, @yo_dona , por visibilizar a mujeres tan increíbles como ella.
Hoy nos hemos ido de gala por un motivo que nos llena de orgullo✨. La Dra. @OlgaMartnezSez1, oncóloga médica en el Centro del Cáncer del @hospitalclinic, ha sido reconocida, como cofundadora de #SOLTIYoung, con el Premio Nuevo Talento en los Premios Poder Femenino de @yo_dona.
1
0
3
RT @_SOLTI: 💡After last Monday’s blackout… we’re back and ready for a new #PollOfTheWeek with a new leader of the initiative for the coming….
0
1
0